We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $28.2B
1-Year Est. Return 115.26%
This Fund
S&P 500
This Quarter Est. Return
+5.51%
1 Year Est. Return
+115.26%
3 Year Est. Return
+356.87%
5 Year Est. Return
+474.2%
10 Year Est. Return
AUM
$16.2B
AUM Growth
-$355M
Cap. Flow
-$629M
Cap. Flow %
-3.9%
Top 10 Hldgs %
26.81%
Holding
380
New
59
Increased
118
Reduced
106
Closed
57

Sector Composition

Rank Sector Weight
1 Technology 35.39%
2 Healthcare 19.78%
3 Financials 16.92%
4 Communication Services 14.5%
5 Consumer Discretionary 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONEM
276
DELISTED
1Life Healthcare
ONEM
$679K ﹤0.01%
+17,378
New +$816K
JOBS
277
DELISTED
51job Inc
JOBS
$660K ﹤0.01%
10,544
-40,020
-79% -$2.67M
THC icon
278
Tenet Healthcare
THC
$21.1B
$643K ﹤0.01%
12,370
-13,786
-53% -$697K
IQ icon
279
iQIYI
IQ
$1.28B
$567K ﹤0.01%
34,111
-170,324
-83% -$3.93M
EDU icon
280
New Oriental
EDU
$8.98B
$560K ﹤0.01%
+4,000
New +$699K
CHNG
281
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$546K ﹤0.01%
24,703
-19,545
-44% -$452K
INSP icon
282
Inspire Medical Systems
INSP
$1.74B
$520K ﹤0.01%
+2,511
New +$534K
ARNA
283
DELISTED
Arena Pharmaceuticals Inc
ARNA
$501K ﹤0.01%
7,225
-5,231
-42% -$403K
NTRA icon
284
Natera
NTRA
$46.4B
$487K ﹤0.01%
4,795
-5,436
-53% -$596K
ICUI icon
285
ICU Medical
ICUI
$4.61B
$457K ﹤0.01%
2,223
OCUL icon
286
Ocular Therapeutix
OCUL
$2.02B
$452K ﹤0.01%
27,539
CHE icon
287
Chemed
CHE
$7.22B
$426K ﹤0.01%
927
-496
-35% -$243K
PGNY icon
288
Progyny
PGNY
$2.2B
$411K ﹤0.01%
+9,223
New +$431K
ESTA icon
289
Establishment Labs
ESTA
$2.28B
$398K ﹤0.01%
6,367
HQY icon
290
HealthEquity
HQY
$8.75B
$386K ﹤0.01%
5,681
+1,300
+30% +$102K
HDB icon
291
HDFC Bank
HDB
$121B
$383K ﹤0.01%
9,866
-15,536
-61% -$609K
SPNE
292
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$346K ﹤0.01%
19,901
IMDX
293
Insight Molecular Diagnostics
IMDX
$156M
$345K ﹤0.01%
+3,326
New +$316K
ASND icon
294
Ascendis Pharma A/S
ASND
$16.8B
$325K ﹤0.01%
2,524
-50,000
-95% -$7.6M
DVAX
295
DELISTED
Dynavax Technologies
DVAX
$300K ﹤0.01%
+30,468
New +$251K
XENT
296
DELISTED
Intersect ENT, Inc
XENT
$268K ﹤0.01%
+12,856
New +$297K
CBAY
297
DELISTED
Cymabay Therapeutics
CBAY
$257K ﹤0.01%
+56,630
New +$305K
SILK
298
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$246K ﹤0.01%
4,854
+300
+7% +$16.7K
YMAB
299
DELISTED
Y-mAbs Therapeutics
YMAB
$243K ﹤0.01%
8,029
-499,604
-98% -$20.5M
IRTC icon
300
iRhythm Holdings
IRTC
$4.2B
$224K ﹤0.01%
1,615
-3,856
-70% -$691K

Similar funds

Polar Capital Holdings's Q1 2021 Portfolio in Review

As of Q1 2021, Polar Capital Holdings held 380 positions worth $16.2B, down 2.1% from $16.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Polar Capital Holdings withdrew a net $629M in Q1 2021, closing 57 positions and reducing 106 holdings. Its most notable exit was Humana, an estimated $90.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Polar Capital Holdings opened a new position in Micron Technology worth $173M.

  • Polar Capital Holdings's largest Q1 2021 buy was Micron Technology: 1,963,601 shares worth $173M.
  • Polar Capital Holdings added most to Alphabet (Google) Class A in Q1 2021, an estimated $136M increase.
  • Polar Capital Holdings's biggest Q1 2021 reduction was Advanced Micro Devices, cutting an estimated $153M.
  • Polar Capital Holdings fully exited Humana in Q1 2021, selling an estimated $90.9M.
  • Polar Capital Holdings's ten largest holdings make up 27% of its $16.2B portfolio in Q1 2021.
  • Polar Capital Holdings opened 59 new positions and closed 57 in Q1 2021.
  • Polar Capital Holdings's portfolio value fell 2.1% quarter-over-quarter to $16.2B.

Based on Polar Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.